Related Experiment Video
Updated: Mar 29, 2026

11:07
A Murine Model of Myocardial Ischemia-reperfusion Injury through Ligation of the Left Anterior Descending Artery
Published on: April 10, 2014
41.5K
[INFLUENCE OF 29-40 AND 65-76 MCP-1 FRAGMENTS ON MYOCARDIUM MORPHOLOGY IN RATS AFTER T9CTHFMIA-R'FPFRFTTON]
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova
|November 24, 2015
Summary
Monocyte chemotactic protein-1 (MCP-1) synthetic fragments alter myocardial inflammation. Peptide IX accelerates monocyte/macrophage infiltration, while Peptide X prolongs inflammation and myocardial damage.
Area of Science:
- Biochemistry
- Immunology
- Cardiology
Context:
- Monocyte chemotactic protein-1 (MCP-1) is a key chemokine in inflammatory responses.
- Myocardial ischemia triggers inflammatory processes involving monocyte and macrophage infiltration.
- Understanding MCP-1's role is crucial for developing targeted therapies for heart disease.
Purpose:
- To investigate the effects of synthetic MCP-1 fragments on inflammatory responses in ischemic myocardium.
- To evaluate the distinct impacts of a monocyte/macrophage migration inductor (Peptide IX) and an inhibitor (Peptide X) on myocardial inflammation.
Summary:
- Administration of synthetic MCP-1 fragments, Peptide IX and Peptide X, induced morphological changes in ischemic myocardium.
- Peptide IX enhanced and accelerated the inflammatory response by increasing monocyte and macrophage recruitment to the site of injury.
- Peptide X resulted in a prolonged inflammatory process, exacerbating myocardial damage.
Impact:
- These findings highlight the potential of MCP-1 fragments in modulating inflammatory timelines during myocardial ischemia.
- The study suggests that Peptide IX could amplify acute inflammatory responses, while Peptide X may prolong chronic inflammation.
- This research provides insights into targeted therapeutic strategies for managing inflammation in ischemic heart conditions.

